Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Pediatr Infect Dis J ; 40(10): 906-911, 2021 10 01.
Article in English | MEDLINE | ID: mdl-34437339

ABSTRACT

BACKGROUND: Antibiotics represent the most widely prescribed drugs in children worldwide, both in hospital and community settings. A comprehensive approach to understanding the reasons and determinants of antibiotic prescription in the pediatric age is needed. This study aimed to assess parents' attitudes and perspectives about antibiotic use. METHODS: Prospective observational study was conducted in all Italian Regions between February 1 and April 30, 2020, using a standardized questionnaire. RESULTS: Six thousand six hundred twenty-five parents from all Italian regions completed the survey. Seventy-six percent of parents were aware that only bacteria are the target of antibiotics, but 92.9% knew that the antibiotic has no direct effect on fever. Antibiotic self-prescription (10.4%) or by remote consultation by phone call (19.9%) or message (9.6%) were relatively common. Ninety-three percent of parents were aware that excessive use of antibiotics could select resistant bacteria and 84.7% of them knew that they could actively fight antibiotic resistance. About two thirds of participants (66.1%) received information on antibiotic resistance from their family pediatrician. Parents born of Italy or those with lower income had a higher probability of having less information from pediatricians or knowledge of proper antibiotic use. DISCUSSION: Our study suggests that parents' knowledge and attitudes toward antibiotic use and prescription are improving compared with previous studies, while there is still a gap regarding antibiotic resistance, particularly on practices that can reduce its burden. Our study's negative finding is that families from low-income settings or those born abroad have significantly more misconceptions about important antibiotic practices.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Health Knowledge, Attitudes, Practice , Parents/psychology , Adult , Child , Child, Preschool , Cross-Sectional Studies , Drug Resistance, Microbial , Fever/drug therapy , Humans , Infant , Italy , Prospective Studies , Respiratory Tract Infections/drug therapy , Surveys and Questionnaires
2.
J Neurosurg Pediatr ; 11(4): 473-7, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23414131

ABSTRACT

Primitive intraneural synovial sarcomas are rare in children. The authors report the case of a 7-year-old girl affected by intraneural synovial sarcoma of a lumbar nerve root, the first such lesion in this location described in a child. The lesion mimicked a schwannoma clinically and radiologically. There was long-lasting leg pain in a radicular distribution, and a well-demarcated intraneural tumor was seen on MRI. On this basis, the first resection was conservative. However, histological examination documented a classic biphasic synovial sarcoma, which was confirmed by immunohistochemistry. After radical resection and adjuvant treatment, complete disease control was achieved and verified at 5-year follow-up. This case strongly suggests that early diagnosis and a multidisciplinary approach to this unusual spinal lesion are essential to achieving a better prognosis.


Subject(s)
Peripheral Nervous System Neoplasms/diagnosis , Peripheral Nervous System Neoplasms/therapy , Sarcoma, Synovial/diagnosis , Sarcoma, Synovial/therapy , Spinal Nerve Roots , Child , Female , Humans , Lumbar Vertebrae
3.
Vaccine ; 28(50): 7825-8, 2010 Nov 23.
Article in English | MEDLINE | ID: mdl-20888873

ABSTRACT

In order to evaluate the immunogenicity, safety, and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with ß-thalassemia major, 31 subjects (19 males; mean age 17.8±8.7 years) with ß-thalassemia major and 28 age- and gender-matched healthy controls were enrolled. Four weeks after vaccination, seroconversion rates were about 80% and seroprotection rates 100% in both groups. Three months after vaccination, most of the subjects remained seroconverted and the seroprotection rates were 93.5% among the patients and 100% among the controls. Safety and tolerability were also very good, with no differences between the groups.


Subject(s)
Adjuvants, Immunologic/pharmacology , Influenza Vaccines/immunology , Influenza, Human/prevention & control , Polysorbates/pharmacology , Squalene/pharmacology , beta-Thalassemia/immunology , Adolescent , Adult , Antibodies, Viral/blood , Antibody Formation , Child , Female , Hemagglutination Inhibition Tests , Humans , Influenza Vaccines/adverse effects , Male , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL